Year |
Citation |
Score |
2021 |
Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 108022. PMID 34687769 DOI: 10.1016/j.pharmthera.2021.108022 |
0.317 |
|
2020 |
Poty S, Mandleywala K, O'Neill E, Knight JC, Cornelissen B, Lewis JS. Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 10: 5802-5814. PMID 32483420 DOI: 10.7150/Thno.44772 |
0.437 |
|
2019 |
Sharma SK, Lyashchenko SK, Park HA, Pillarsetty N, Roux Y, Wu J, Poty S, Tully KM, Poirier JT, Lewis JS. A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals. Nuclear Medicine and Biology. 71: 32-38. PMID 31128476 DOI: 10.1016/J.Nucmedbio.2019.04.005 |
0.477 |
|
2019 |
Curado N, Dewaele-Le Roi G, Poty S, Lewis JS, Contel M. Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines. Chemical Communications (Cambridge, England). PMID 30632546 DOI: 10.1039/C8Cc08769E |
0.327 |
|
2019 |
Poty S, Knight JC, Donabedian P, Mandleywala K, Cornelissen B, Reiner T, Lewis JS. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model Journal of Medical Imaging and Radiation Sciences. 50: S4-S5. DOI: 10.1016/J.Jmir.2019.03.014 |
0.468 |
|
2018 |
Poty S, Carter LM, Mandleywala K, Membreno R, Abdel-Atti D, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS. Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30352909 DOI: 10.1158/1078-0432.Ccr-18-1650 |
0.553 |
|
2018 |
Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies _ Part 1. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29545378 DOI: 10.2967/Jnumed.116.186338 |
0.32 |
|
2018 |
Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. Alpha Emitters for Radiotherapy: Basic Radiochemistry to Clinical Studies - Part 2. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29496984 DOI: 10.2967/Jnumed.117.204651 |
0.303 |
|
2018 |
Carter LM, Poty S, Sharma SK, Lewis JS. Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29412489 DOI: 10.1002/Jlcr.3612 |
0.505 |
|
Show low-probability matches. |